SIMONE, Angela
 Distribuzione geografica
Continente #
NA - Nord America 1.203
EU - Europa 920
AS - Asia 289
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.416
Nazione #
US - Stati Uniti d'America 1.199
IE - Irlanda 276
SE - Svezia 259
CN - Cina 168
SG - Singapore 90
IT - Italia 82
UA - Ucraina 70
DE - Germania 50
GB - Regno Unito 49
FI - Finlandia 41
BE - Belgio 26
PL - Polonia 26
AT - Austria 22
IN - India 20
RU - Federazione Russa 10
CA - Canada 4
CZ - Repubblica Ceca 4
FR - Francia 4
VN - Vietnam 4
ID - Indonesia 2
JP - Giappone 2
KR - Corea 2
AU - Australia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 2.416
Città #
Chandler 306
Dublin 275
Jacksonville 151
Nyköping 135
Ann Arbor 77
Beijing 73
Singapore 73
Ashburn 71
New York 45
Medford 41
Princeton 41
Cambridge 38
Dearborn 33
Des Moines 31
Boardman 30
Brussels 26
Warsaw 24
Vienna 22
Lancaster 21
Messina 14
Jinan 12
Woodbridge 12
Haikou 11
Pune 11
Nanjing 9
Wilmington 9
Hangzhou 8
Bremen 7
Ningbo 7
Shenyang 7
Tianjin 7
Hebei 6
Los Angeles 6
Genova 5
San Mateo 5
Washington 5
Dong Ket 4
Hyderabad 4
Auburn Hills 3
Brno 3
Changsha 3
Clearwater 3
Jiaxing 3
Redwood City 3
Rome 3
Taiyuan 3
Zhengzhou 3
Catanzaro 2
Dongdaemun-gu 2
Florence 2
Fuzhou 2
Guangzhou 2
Helsinki 2
Jakarta 2
Kemerovo 2
Leawood 2
Saint Petersburg 2
Taizhou 2
Wroclaw 2
Ardabil 1
Athens 1
Augusta 1
Cairo 1
Clifton 1
Dunedin 1
Fredericton 1
Hefei 1
Henderson 1
Ivry-sur-Seine 1
Lanzhou 1
Lappeenranta 1
Longueuil 1
Lucan 1
Lucera 1
Meieki 1
Melbourne 1
Mumbai 1
Munich 1
Nanchang 1
Nanning 1
Naples 1
Norwalk 1
Novokuznetsk 1
Ottawa 1
Prague 1
Riva 1
Saint Louis 1
San Francisco 1
The Dalles 1
Tokyo 1
Tomsk 1
Toronto 1
Torregrotta 1
Totale 1.747
Nome #
Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening 89
Detection and genotyping of human papillomavirus in gynaecologic outpatients of Messina, eastern Sicily, Italy. 83
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 78
HER-2 overexpression in advanced node-positive gastric carcinomas: is there any relationship with other clinico-pathological histoprognostic parameters? 77
Lactoferrin expression in colorectal cancer: relationships with proliferation indices and survival. 75
BRAF mutation testing on melanoma brain metastases 74
Relationship between the presence of high risk HPV DNA and proliferation rate in cervical intraepithelial neoplasia 73
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 71
Immunohistochemical evidence of metallothionein in neoplasms of liver, gallbladder and pancreas 70
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas 68
Immunohistochemical study of HER-2 overexpression in indolent gastric carcinomas. 67
BRAF mutation testing on melanoma brain metastases 66
Human papillomavirus typing in gynaecologic outpatients in Messina, Italy. 66
HER2 analysis in sporadic thyroid cancer of follicular cell origin 63
Analysis of genomic low copy number DNA from cells harvested by laser-microdissection 62
Human Papillomavirus Types Distribution in Eastern Sicilian Females with cervical lesions. A Correlation with Colposcopic and Histological Findings. 60
Clearance and persistence of human papillomavirus infections in patients with lesions of the cervix 60
Immunoexpression of cyclooxygenase (COX)-2 in long-standing ulcerative colitis. 60
Immunohistochemical evidence of lactoferrin in human adult normal and neoplastic cartilage 57
KRAS mutation testing on endoscopic biopsy of primary colorectal cancer 57
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 56
Immunohistochemical expression of metallothionein in primary hepatocellular carcinoma and liver metastases 54
Extended RAS mutation testing on wild-type KRAS exon 2 metastatic colorectal cancer. 54
Heterogeneity of KRAS mutational status in colorectal adenocarcinomas with a mucinous component 54
Immunolocalization of lactoferrin in human bone tumours: an investigation by monoclonal antiserum. 52
IMMUNOLOCALIZATION OF LACTOFERRIN IN HUMAN SPORADIC RENAL CELL CARCINOMAS: AN INVESTIGATION BY MONO- AND POLYCLONAL ANTISERA. 52
Expression of lactoferrin mRNA in human breast cancer cells selected by laser-microdissection. 52
Heterogeneity of K-Ras mutation status in colorectal adenocarcinomas with a mucinous component. 51
Laser microdissection and DNA typing of cells from single hair follicles 50
MGMT promoter methylation status in different portions of surgically resected glioblastomas 47
Single sperm cell isolation by laser microdissection 46
Lactoferrin immunoexpression in endometrial carcinomas: Relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival 46
KRAS mutation testing on different areas of primary colorectal adenocarcinomas with mucinous component 44
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes. 44
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 43
Her-2 expression in differentiated thyroid carcinoma (DTC): an immunohistochemical characterization in view of targeted therapies 42
Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case 39
Immunohistochemical expression of somatostatin receptors sst2A in human meningiomas: is there any relevance with clinico-pathological parameters ? 37
RAS testing in colorectal carcinoma: experience from a single institution of eastern Sicily 36
Molecular analysis of genomic low copy number DNA exracted from laser-microdissected cells. 34
Liquid biopsy in non-small cell lung cancer: a comparison between different methodologies to detect somatic mutations 34
Immunohistochemical expression of HER2 in thyroid cancer. 31
null 31
null 18
null 15
Totale 2.438
Categoria #
all - tutte 10.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 0 0 15 34 30 38 6 60 36 5
2020/2021298 29 8 53 41 30 21 9 15 6 48 23 15
2021/2022350 6 63 6 18 5 6 16 10 6 77 37 100
2022/2023956 66 92 35 113 67 112 16 48 376 5 16 10
2023/2024254 25 29 10 25 23 89 8 8 1 12 2 22
2024/202599 10 3 15 53 18 0 0 0 0 0 0 0
Totale 2.438